While, Sun Pharma was the biggest losers in the Sensex pack, falling up to 9 per cent, on reports that markets regulator Sebi was likely to reopen an insider trading case against the company as well as probe alleged lapses by some of its promoters and other entities in raising funds overseas.

The development comes after a whistleblower reportedly approached Sebi with a document alleging various irregularities by the company, its promoter Dilip Shanghvi and others, sources said.


we are the best